Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data in cystic fibrosis disclosed on TR-02

May 25, 2010

Ranolazine exhibits antifibrillatory activity during severe coronary stenosis

May 25, 2010

Acute rejection rates similar with CP-690550 and ciclosporin in renal transplant patients

May 25, 2010

AGN-203818 useful to reduce hypersensitivity in heartburn and IBS patients

May 25, 2010

GAP-107B8 active against ovarian cancer

May 21, 2010

Ad5.SSTR/TK.RGD/ganciclovir active in phase I trial in gynecologic cancer

May 21, 2010

Dofetilide shows clinical potential for treatment of persistent AF

May 21, 2010

Diannexin reduces ischemia/reperfusion injury in renal transplant recipients

May 21, 2010

TOL-101 antibody modulates T-cell responses in vitro and in vivo

May 21, 2010

Updates on ADX-10059 for clinical management of GERD

May 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...